Healthpoint, part of the M42 group, has recently boosted its multi-specialty facility with the introduction of Oral and Maxillofacial Surgery (OMFS). This new specialty is set to enhance the range of services available to patients by offering expert diagnosis, treatment, and management of a
oral
New Hope Against The Disease The World Health Organization (WHO) has granted prequalification to a new oral vaccine for cholera, marking a pivotal development in global health. The inactivated oral vaccine Euvichol-S received the WHO’s stamp of approval on April 12, 2024. Its simplified formulation promises to scale up production capacity rapidly. Dr Rogerio Gaspar,